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ABSTRACT
Objective: The aim of this study is to investigate the antihyperglycemic activity of tinocrisposide by stimulating 3T3-L1 adipocyte cell differentiation. 
Tinocrisposide is a furanoditerpene glycoside that was isolated from Tinospora crispa (Menispermaceae).
Methods: Adipocyte cell differentiation activity of tinocrisposide in interval concentrations of 50, 25, 12.5, and 6.25 µg/ml has been investigated 
on 3T3-L1 cell line using insulin of 1 µg/ml as a positive and Dulbecco’s modified Eagle media (DMEM) as a negative control group. The effect of 
tinocrisposide was quantified with oil red O staining method by measuring an absorbance of lipid solution in isopropanol at a wavelength (λ) of 
520 nm.
Results: Tinocrisposide in the concentrations of 50, 25, 12.5, and 6.25 µg/ml insulin of 1 µg/ml and DMEM groups showed absorbance value of 
0.7669, 0.7253, 0.6563, 0.6481, 0.954, and 0.2653, respectively. It was found that there was a significant difference statistically in lipid droplets 
accumulation among all groups (p<0.05) and tinocrisposide at a concentration of 50 µg/ml showed the highest lipid droplets accumulation in 3T3-L1 
adipocyte cells.
Conclusion: From the study, it could be concluded that tinocrisposide was able to stimulate the differentiation of adipocyte cell and had 
antihyperglycemic activity.
Keywords: 3T3-L1 adipocyte cell differentiation, Antihyperglycemic, Tinocrisposide, Tinospora crispa.
INTRODUCTION
The incidence of diabetes mellitus (DM) case is increasing tremendously 
in most part of the world, especially in developing countries. This 
disease causes substantial morbidity, mortality, and long-term 
complications such as retinopathy, neuropathy, and nephropathy [1]. 
DM is a chronic metabolic disorder characterized by hyperglycemia 
resulting from defects in insulin secretion, insulin action, or both. It is 
well documented that chronic hyperglycemia of diabetes is associated 
with a series of pathological changes, tissue damages, and eventually 
leads to the failure of organ function. The target organs and tissues 
include the eyes, kidneys, nerves, heart, and blood vessels [2].
Medicinal plants are very important resources for drug candidates and 
were targeted for finding new drugs to treat various medical conditions. 
Medicinal plants have an advantage as drugs resources because they 
contain relatively high bioactive compound [3]. Tinospora crispa (L.) 
Miers Hook f. and Thoms (Menispermaceae) is a climbing plant that 
found in the tropic and subtropical region of Asia, such as Indonesia, 
Malaysia, Thailand, and India, and for a long time, it has been used 
traditionally as antidiabetic drugs.
Ethanol extract of T. crispa has an effect to decrease blood glucose 
concentration on experimental diabetic rats. This hypoglycemic effect 
was likely due to by insulinotropic mechanism [2]. From methanol 
extract of dried pulverized T. crispa stems, tinocrisposide (C27H36O11) 
has been isolated, a furanoditerpene glycoside with a very bitter 
taste [4]. It is considered that tinocrisposide is responsible for some 
biological activity of T. crispa stem extracts so that it has been used as 
an antidiabetic treatment in traditional medicine (Fig. 1).
In a previous study, we have investigated the effect of tinocrisposide 
in lowering of blood glucose level on alloxan-induced hyperglycemic 
mice [5]. Adipocyte cells have a function as a blood glucose level 
regulation, therefore it can be as one of antihyperglycemic drugs 
target. Differentiated adipocyte cells are sensitive to insulin because 
exposure to insulin increases the number of insulin’s receptor on its 
cell membrane. In the present study, an antihyperglycemic activity of 
tinocrisposide has been discovered in vitro using 3T3-L1 adipocyte cell 
and its results will be reported in this article.
MATERIALS AND METHODS
Materials
Mice 3T3-L1 preadipocyte, obtained from ATCC (Rockville, MD, USA), 
were grown in Dulbecco’s modified Eagle’s medium (DMEM) Gibco 
(Paisley, UK) supplemented with 10% bovine calf serum Gibco 
(Paisley, UK), and antibiotics (100 U/ml penicillin and 100 μg/ml 
streptomycin) Gibco (Paisley, UK) at 37°C under a humidified 5% CO2 
atmosphere. Cells were subcultured every 3–4 days at approximately 
80% confluence.
Instruments
Class II biological safety cabinet (Jouan MSC 12, Thermo Fisher 
Scientific, USA), Hemocytometer (Hirschmann, EM Techcolor, Germany), 
Inverted Microscope (TC 5400, Meiji Techno, Japan), Hemocytometer 
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(Hirschmann, EM Techcolor, Germany), Microplate reader (Dynatech 
MR5000 TECAN, Tecan Group Ltd., Switzerland), (Thermo Fisher 
Scientific, USA), Autoclave (HV-85, Hirayama, Japan), CO2 Incubator 
(NU-5100E, Nuaire, USA), and Light microscope (Motic B2 series, Motic 
Asia, Hongkong) were used.
Experimental procedure
Cell viability assay
Cell viability was assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assay as described by Parimala 
et al., 2015. Mature adipocyte cells were seeded in 96-well plates 
and grown until 80–90% confluence. Tinocrisposide was dissolved 
in dimethylsulfoxide (DMSO) to get the solutions in concentrations 
interval from 3.125 to 100 µg/ml (Table 1). Our preliminary study 
showed that DMSO at a concentration of <0.1% in media did not affect 
cell viability or differentiation. Each concentration of tinocrisposide 
was added to mature adipocytes in 96-well plates and incubated for 2 h 
at 37°C. Cells were then washed 2 times with phosphate buffer saline 
(PBS) and 10 µl of MTT stock solution (5 mg/ml) was added to each 
well and the plates were further incubated for 4 h at 37°C under 5% CO2 
atmosphere. Then, the supernatant was discarded and 200 µl of DMSO 
was added to each well to solubilize the water insoluble formed purple 
formazan crystals, and the solutions were stored at room temperature 
in the dark place.
After 1 h, the absorbance was measured at a wavelength of 550 nm 
and a reference wavelength of 630 nm with a microplate reader. Cell 
viability was calculated then according to the following equation.
% Viability = [(A treated group – A medium)/(A untreated – A medium)] 
×100%
Adipocyte cell differentiation
Cells were seeded into 4-well plates at a density of 2×104 cells/
well. 2 days after experiment cells became confluence (defined as 
day-0), cells were stimulated gently to differentiate with a medium 
containing DMEM, 10% fetal bovine serum (FBS), and MDI (0.5 mM 
3-isobutyl-1-methylxanthine [IBMX], 0.25 µM dexamethasone, and 
1 µg/ml insulin) for 2 days. In the course of screening adipocyte 
differentiation-stimulated activity, 3T3-L1 preadipocyte was treated 
with differentiation medium in the presence of various concentrations 
of tinocrisposide (6.25, 12.5, 25, and 50 µg/ml) at day-0 (Table 1).
Concentrations of tinocrisposide were selected based on toxicity 
assay, where the concentration of 6.25 and 50 µg/ml showed viability 
adipocyte cells of 72.8492% and 61.8871%, respectively (as presented 
in Table 2). At day-2, differentiating medium was replaced with the 
mixture 10% FBS and DMEM medium containing 1 µg/mL insulin and 
incubated properly for another 2 days (day-4). Thereafter, the cells 
were maintained in 10% FBS/DMEM medium for an additional 4 days 
(day-8) with medium changes every 2 days [7].
Oil red O staining
8 days after the differentiation induction, mature adipocyte cells were 
washed 3 times with PBS and fixed with 10% formalin for 1 h at room 
temperature. After fixation, cells were washed directly once used PBS 
and stained immediately with freshly diluted oil red O-solution (three 
parts of 0.6% oil red O in isopropanol and two parts of distilled water) 
for 1 h. Cells were then washed twice with distilled water and visualized 
under a microscope. All experiment images were taken and collected by 
an Olympus (Tokyo, Japan) microscope.
Quantitative analysis of oil red O staining
Oil red O-stain was dissolved with isopropanol and optical density was 
measured at 520 nm by enzyme-linked immunosorbent assay plate 
reader [7].
Oil red O staining process
After differentiation, the cells were fixed for 1 h at room temperature 
with 10% formalin in PBS, washed 3 times with PBS, and then stained 
for 1 h with filtered oil red O (0.5% in 60% isopropanol). After the cells 
were washed 3 times with distilled water, the cells were photographed 
under a microscope. Lipid and oil red O were extracted using 
isopropanol, and absorbance was measured using a spectrophotometer 
at a wavelength of 520 nm [6].
RESULTS AND DISCUSSION
Effect of tinocrisposide on the viability of 3T3-L1 adipocyte cells
The viability assay was used to determine any possible toxicity effect 
of tinocrisposide on the cells. Mature adipocyte cells were treated 
with various tinocrisposide concentrations. The viability of cell was 
quantified with MTT method by measuring the absorbance of a formed 
formazan solution at λ 550 nm with a microplate reader (Table 2).
Data in Table 2 showed that treatment 3T3-L1 adipocyte cells with 
tinocrisposide in concentration level of 3.125, 6.25, 12.5, 25, 50, and 
100 µg/ml exerted the cell viability of 88.9916, 72.8492, 69.2414, 
65.5411, 61.8871, and 56.7992%, respectively. High concentration of 
tinocrisposide can exert the toxicity effect on adipocyte cells; therefore, 
tinocrisposide was used in following adipocyte differentiation assay in 
the concentration levels of 3.125–50 µg/ml. The IC50 of tinocrisposide 
toward adipocyte cell 3T3-L1 was calculated by regression equation and 
it found to be at 102.29 µg/ml. It can be concluded that tinocrisposide 
has low toxicity toward 3T3-L1 adipocyte cell (IC50 ≥100 µg/ml).
Tinocrisposide effect on adipocyte cell differentiation
Intracellular triglyceride droplets which indicate that adipocyte cell 
begins to differentiate were observed at day-4 of differentiation. In the 
Table 1: Differentiation scheme of adipocyte cells
Day Negative control Positive control Treatment group





Tinocrisposide (6.25, 12.5, 25, and 50 µg/ml)
2 No inducer (DMEM) Insulin (100 nM) Insulin (100 nM)
4–8 Complete medium Complete medium Complete medium
DMEM: Dulbecco’s Modified Eagle media
Fig. 1: Chemical structure of tinocrisposide [4]
496
Asian J Pharm Clin Res, Vol 11, Issue 11, 2018, 494-498
 Adnan et al. 
following day, the number and the diameter of triglyceride droplets 
increased. 8 days after treatment, preadipocyte differentiation was 
terminated and stained with oil red O. Triglyceride droplets in these 
cells were visualized and photographed (Fig. 2).
Tinocrisposide increases intracellular lipid accumulation in 3T3-
L1 adipocyte cell
Quantification of lipid accumulation of negative control group 
(DMEM), IBMX-dexamethasone group, and tinocrisposide with 
various concentrations (6.25, 12.5, 25, and 50 µg/ml) and positive 
control group (insulin 1 µg/ml) using spectrophotometer at λ 520 nm 
showed absorbance of 0.2653, 0.4043, 0.6481, 0.6563, 0.7253, 0.7669, 
and 0.9504, respectively (Table 3 and Fig. 2). Absorbance data were 
processed by statistical method to determine the statistical difference 
among the groups (p<0.05).
The data in Table 3 showed that absorbance of tinocrisposide of 
all treatment doses was higher and significantly different then 
absorbance of IBMX-dexamethasone group (p<0.05) which means that 
tinocrisposide stimulated the adipocyte cell differentiation in a dose-
dependent manner. The tinocrisposide showed maximum adipogenic 
activity at a dose of 50.0 µg/ml and had stimulating activity at 189% 
relative to MDI-treated control cells and 80.6% relative to positive 
control group (insulin 1 µg/ml). It could be concluded from this study 
that tinocrisposide could stimulate adipocyte differentiation, but it 
is not as strong as the stimulation caused by insulin (1 µg/ml). Data 
on tinocrisposide concentrations and formed triglyceride solution 
absorbance at λ 520 nm were processed by Microsoft Excel Software 
as shown in Fig. 3.
A linear correlation (R = 0.9643) was found between the concentration 
of treated tinocrisposide and the formed triglyceride solution 
absorbance. This finding supported the evidence that tinocrisposide 
has an adipogenic activity in a concentration-dependent manner.
Adipocyte plays a key role in the control of systemic glucose and 
lipid homeostatic [8,9]. Glucose uptake will increase adipocyte cell 
differentiation. Differentiated adipocyte cell is more responsive 
to the hormones that play a role in the regulation of glucose 
metabolism [10]. One of the hormones that very important in adipocyte 
cells differentiation is insulin, which stimulates glucose uptake in 
differentiated adipocyte cells [11,12]. Adipocyte was recognized as 
central players in the pathogenesis of insulin resistance. Adipocyte acts 
as free fatty acid (FFA) storage depot [13] and increasing the capacity 
of adipocyte to store FFA leads to insulin resistance [14]. Adipocytes 
secret multiple hormones and cytokines which directly regulate body 
insulin sensitivity [13,15].
Differentiation of adipocyte cells will follow by promoting of insulin 
sensitivity [9,16]. During the terminal phase of differentiation, activation 
of a transcriptional cascade leads to increasing glucose transporter and 
insulin receptor [16]. Insulin will phosphorylate insulin receptors (IRs) 
that are followed by phosphorylation process of receptors substrate 
(IRS)-1 and IRS-2 that leads to the activation of phosphoinositide 
3-kinase (IP3K) signaling. IP3K activating provides the translocation 
of glucose transporter-4 (GLUT-4) from vesicle in sitosol toward cell 
membrane to facilitate glucose uptake into adipocyte cells [9].
Inability of adipocyte cell to differentiate is one of the pathological 
factors of some metabolic diseases such as diabetes [6,17]. In our study, 
tinocrisposide stimulated adipocyte differentiation that increased its 
insulin sensitivity. Various concentrations of tinocrisposide showed 
higher adipocyte cell 3T3-L1 differentiation then negative control 
DMEM and MD (p<0,05). The stimulating effect of tinocrisposide on 
adipocyte cell differentiation was higher than MD but slightly lower 
than the positive control (insulin). Meanwhile, Saraphanchotiwitthaya 
and Sripalakit determined the in vitro antiobesity effects of Morinda 
citrifolia leaf extract and herbal formulas used traditionally for weight 
loss in Thailand on lipid accumulation in 3T3-L1 adipocytes [18].
Adipocyte cells differentiation is a multistep process involving a 
cascade of transcription factors [13] and cell-cycle proteins regulating 
gene expression and leading to adipocyte development [19]. Some 
proteins that expressed in differentiated adipocyte cells were CCAAT/
enhancer-binding protein (C/EBP) α and peroxisome proliferator-














Table 3: Absorbance of cellular triglyceride solutions at 520 nm
Treated group Absorbance
Negative control group (DMEM) 0.2653
IBMX-dexamethasone group 0.4043
Tinocrisposide 6.25 µg/ml 0.6481
Tinocrisposide 12.5 µg/ml 0.6563
Tinocrisposide 25.0 µg/ml 0.7253
Tinocrisposide 50.0 µg/ml 0.7669
Positive control group (insulin 1 µg/ml) 0.9504
DMEM: Dulbecco’s Modified Eagle media
Fig. 2: Adipocyte cell morphology on day-8, before and after ORO staining, (a) negative control, (b) tinocrisposide 6.25 µg/ml, (c) 
tinocrisposide 12.5 µg/ml, (d) tinocrisposide 25 µg/ml, (e) tinocrisposide 50 µg/ml, (f) positive control (insulin 100 nM)
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activated receptor (PPARγ) [20]. C/EBP α [21] and PPARγ have a 
function as a regulation master of adipocyte cell differentiation [7,22]. 
C/EBP α induces many adipocyte genes directly during differentiation, 
such as 442 (aP2) [23] and stearoyl-CoA desaturation I (SCD1), that has 
a function in fat metabolism and so that blood fatty acid level can be 
reduced [24,25]. PPARγ is a master regulator of adipogenesis [15] and 
its expression will increase the expression of 442 (aP2) [22], SCD1, IR, 
IRS-2, and GLUT-4. It will increase uptake of the FFA and store it in the 
form of triglyceride molecule; furthermore, it will increase uptake of 
glucose into adipocyte cell [9].
Adipocyte cells fail to express of C/EBP α and PPARγ lead to failure 
of adipocyte cell differentiation and it was followed by insulin 
resistance [21]. At present, available full PPARγ agonists represented 
by thiazolidinediones (e.g., pioglitazone) are clinically effective, but 
they have a serious side and off-target effects (e.g., weight gain or 
edema formation), urging the retrieval of new PPARγ agonists [26]. 
Tinocrisposide might have stimulated the adipocyte cell differentiation 
by promoting the expression of C/EBP α and PPARγ. Expression 
increasing of C/EBP α and PPARγ by tinocrisposide will raise the 
protein expression of 442 (aP2) [22], SCD 1, IRS-2, IR, and GLUT-4 
that increases FFA and glucose uptake into adipocyte cell that follows 
by enhancing insulin sensitivity which provides the antihyperglycemic 
effect of tinocrisposide. The research should be continued with the gene 
expression analysis as described by Sitepu et al. [27] and gene expression 
that might be affected by tinocrisposide could be investigated.
CONCLUSION
Tinocrisposide stimulated the 3T3-L1 adipocyte cell differentiation. 
Adipocyte cell differentiation activity of tinocrisposide was found much 
higher than negative control and MD groups but slightly lower than 
insulin. We believed that the antihyperglycemic effect of tinocrisposide 
was realized by its capability to stimulate adipocyte differentiation 
which in the end will increase the adipocyte insulin sensitivity, thus 
enhancing the adipocyte FFA and glucose uptake.
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